RxDoctor Payments Data

Ammar Hawasli, MD

Neurological Surgery · North Kansas City, MONPI 1750519112

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 46.8% of the total. Reporting peaked in 2019 at $7,630 and has fallen 90.1% since, to $756 in 2025.

$10,429in general payments, 2019–2025

Across 57 payments — averaging $182.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$5K
  • Cerapedics Inc.$2K
  • Medtronic$1K
  • Globus Medical$1K
  • Highridge Medical LLC$314
  • Stryker$234
  • plus $752 from 9 others

What the payments were for

  • Consulting fees$4,05239%
  • Speaking & faculty fees$1,50014%
  • Travel & lodging$1,85918%
  • Food & beverage$3,01729%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,429 in reported general payments places this provider in the 70th percentile of 172 neurological surgery providers in Missouri.

See all neurological surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$271,049
Medicare patients
400
Services billed
941

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl238$3,555
Gabapentin198$2,464
Oxycodone Hcl163$961
Celecoxib50$927
Meloxicam250$690
Pregabalin55$594
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$500
Methocarbamol31$450
Cyclobenzaprine Hcl35$379
Methylprednisolone31$201
Baclofen16$175
Tramadol Hcl26$90
Lorazepam13$6

Paid to pharmacies, not to this prescriber.

Other neurological surgery in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →